Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Controlled Crossover Trial to Evaluate the Effects of Ambulatory Oxygen on Health Status in Patients With Fibrotic Lung Disease (FLD).

NCT02286063 is registered in ClinicalTrials.gov with Royal Brompton & Harefield NHS Foundation Trust as lead sponsor.

NCT NCT02286063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02286063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Controlled Crossover Trial to Evaluate the Effects of Ambulatory Oxygen on Health Status in Patients With Fibrotic Lung Disease (FLD).
Lead sponsor
Royal Brompton & Harefield NHS Foundation Trust
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2014
Completion date
January 31, 2018
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung; disease, fibroid (chronic)